Advertisement
Screener

AngioDynamics, Inc. (ANGO) Deferred Revenue Recognized

2.8 / 5 stars · 68/120 Roast Me

AngioDynamics, Inc. Deferred Revenue Recognized

AngioDynamics, Inc. (ANGO) reported Deferred Revenue Recognized of $300.00 thousand for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-04-02.

Financial Statements › Income Statement › Other Income

us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-04-02

  • AngioDynamics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-08-31 was $100.00K, a 0.00% change year-over-year.
  • AngioDynamics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2024-08-31 was $100.00K.
  • AngioDynamics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2021-08-31 was $400.00K, a 0.00% change year-over-year.
  • AngioDynamics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2020-08-31 was $400.00K, a 100.00% increase year-over-year.
  • AngioDynamics, Inc. contract with customer, liability, revenue recognized for fiscal 2021 was $1.20M, a 45.45% decline from fiscal 2020.
  • AngioDynamics, Inc. contract with customer, liability, revenue recognized for fiscal 2020 was $2.20M, a 100.00% increase from fiscal 2019.
  • AngioDynamics, Inc. contract with customer, liability, revenue recognized for fiscal 2019 was $1.10M.
Period endContract with Customer, Liability, Revenue Recognized 3 monthContract with Customer, Liability, Revenue Recognized 6 monthContract with Customer, Liability, Revenue Recognized 9 monthContract with Customer, Liability, Revenue Recognized 12 month
2026-02-28$300.00K
10-Q · filed 2026-04-02
2025-11-30$100.00K
10-Q · filed 2026-01-06
2025-08-31$100.00K
10-Q · filed 2025-10-02
2025-02-28$300.00K
10-Q · filed 2025-04-02
2024-11-30$200.00K
10-Q · filed 2025-01-08
2024-08-31$100.00K
10-Q · filed 2024-10-03
2024-02-29$300.00K
10-Q · filed 2024-04-09
2023-11-30$200.00K
10-Q · filed 2024-01-08
2021-11-30$500.00K
10-Q · filed 2022-01-07
2021-08-31$400.00K
10-Q · filed 2021-09-30
2021-05-31$1.20M
10-K · filed 2021-07-27
2021-02-28$1.00M
10-Q · filed 2021-03-31
2020-11-30$700.00K
10-Q · filed 2021-01-08
2020-08-31$400.00K
10-Q · filed 2020-10-07
2020-05-31$2.20M
10-K · filed 2021-07-27
2020-02-29$1.60M
10-Q · filed 2020-04-08
2019-11-30$600.00K
10-Q · filed 2020-01-08
2019-08-31$200.00K
10-Q · filed 2019-10-04
2019-05-31$1.10M
10-K · filed 2020-08-10
2019-02-28$700.00K
10-Q · filed 2019-04-02
2018-11-30$200.00K
10-Q · filed 2019-01-07
2018-08-31$100.00K
10-Q · filed 2018-10-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
SI-BONE, Inc. (SIBN)United States$0.830B-49.82